CUAMC
IMVT icon

China Universal Asset Management Company’s Immunovant IMVT Stock Holding History

China Universal Asset Management Company’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
33,925
-3,793
-10% -$116K 0.08% 182
2026
Q1 		$937K Buy
37,718
+9,157
+32% +$237K 0.07% 199
2025
Q4 		$726K Sell
28,561
-1,994
-7% -$44.5K 0.06% 215
2025
Q3 		$493K Sell
30,555
-3,774
-11% -$61.1K 0.04% 251
2025
Q2 		$549K Buy
34,329
+258
+0.8% +$3.9K 0.05% 233
2025
Q1 		$582K Buy
34,071
+2,947
+9% +$61.6K 0.05% 238
2024
Q4 		$771K Buy
31,124
+2,973
+11% +$84.3K 0.07% 197
2024
Q3 		$803K Buy
28,151
+10,991
+64% +$324K 0.09% 158
2024
Q2 		$453K Sell
17,160
-10,776
-39% -$307K 0.06% 154
2024
Q1 		$903K Buy
27,936
+11,202
+67% +$409K 0.11% 135
2023
Q4 		$705K Buy
16,734
+13,374
+398% +$492K 0.14% 128
2023
Q3 		$129K Buy
3,360
+1,651
+97% +$37.3K 0.04% 177
2023
Q2 		$32.4K Sell
1,709
-55
-3% -$1.03K 0.01% 232
2023
Q1 		$27.4K Buy
1,764
+452
+34% +$7.84K 0.01% 191
2022
Q4 		$23.3K Buy
1,312
+220
+20% +$2.77K 0.01% 166
2022
Q3 		$6K Buy
+1,092
New +$5.34K ﹤0.01% 253

Other funds holding IMVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

China Universal Asset Management Company's IMVT Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Immunovant (IMVT) stake by 10% in Q2 2026, selling an estimated $116K and leaving 33,925 shares worth $1.31M. The position accounts for 0.08% of the portfolio, ranked #182.

China Universal Asset Management Company first reported a position in IMVT in Q3 2022 and has held it in 16 quarters since. 137 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • China Universal Asset Management Company held 33,925 shares of Immunovant worth $1.31M as of Q2 2026.
  • China Universal Asset Management Company sold 3,793 Immunovant shares in Q2 2026, an estimated $116K.
  • Immunovant made up 0.08% of China Universal Asset Management Company's portfolio in Q2 2026, its #182 holding.
  • China Universal Asset Management Company first reported a position in Immunovant in Q3 2022 and has held it in 16 quarters since.
  • 137 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.